Skip to main content

Advertisement

Open Peer Review Reports for: Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
28 Jul 2015 Submitted Original manuscript
24 Sep 2015 Reviewed Reviewer Report - Martin Haag
25 Sep 2015 Reviewed Reviewer Report - Jiejie Xu
26 Oct 2015 Author responded Author comments - Jifang gong
Resubmission - Version 2
26 Oct 2015 Submitted Manuscript version 2
4 Nov 2015 Reviewed Reviewer Report - JIN LI
11 Nov 2015 Reviewed Reviewer Report - Jiejie Xu
4 Dec 2015 Author responded Author comments - Jifang gong
Resubmission - Version 3
4 Dec 2015 Submitted Manuscript version 3
15 Jan 2016 Author responded Author comments - Jifang gong
Resubmission - Version 4
15 Jan 2016 Submitted Manuscript version 4
Publishing
28 Jan 2016 Editorially accepted
8 Feb 2016 Article published 10.1186/s12885-016-2092-9

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement